183 related articles for article (PubMed ID: 20045276)
1. Ultra high-pressure liquid chromatographic assay of moxifloxacin in rabbit aqueous humor after topical instillation of moxifloxacin nanoparticles.
Jain GK; Jain N; Pathan SA; Akhter S; Talegaonkar S; Chander P; Khar RK; Ahmad FJ
J Pharm Biomed Anal; 2010 May; 52(1):110-3. PubMed ID: 20045276
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.
Vasavada AR; Gajjar D; Raj SM; Vasavada V; Vasavada V
J Cataract Refract Surg; 2008 Aug; 34(8):1379-82. PubMed ID: 18655991
[TBL] [Abstract][Full Text] [Related]
3. Vitreous and aqueous penetration of orally and topically administered moxifloxacin.
Fukuda M; Shibata N; Osada H; Yamashiro Y; Sasaki H
Ophthalmic Res; 2011; 46(3):113-7. PubMed ID: 21325873
[TBL] [Abstract][Full Text] [Related]
4. The effect of cataract surgery on ocular levels of topical moxifloxacin.
Mather R; Stewart JM; Prabriputaloong T; Wong J; McLeod SD
Am J Ophthalmol; 2004 Oct; 138(4):554-9. PubMed ID: 15488780
[TBL] [Abstract][Full Text] [Related]
5. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.
Lai WW; Chu KO; Chan KP; Choy KW; Wang CC; Tsang CW; Pang CP
Am J Ophthalmol; 2007 Aug; 144(2):315-8. PubMed ID: 17659971
[TBL] [Abstract][Full Text] [Related]
6. Conjunctival concentrations of a new ophthalmic solution formulation of moxifloxacin 0.5% in cataract surgery patients.
Lindstrom R; Lane S; Cottingham A; Smith S; Sall K; Silverstein S; Shettle L; Walters T; Faulkner R; Cockrum P; Teuscher N
J Ocul Pharmacol Ther; 2010 Dec; 26(6):591-5. PubMed ID: 20925517
[TBL] [Abstract][Full Text] [Related]
7. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
Holland EJ; Lane SS; Kim T; Raizman M; Dunn S
Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
[TBL] [Abstract][Full Text] [Related]
8. Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty.
Fukuda M; Yamada M; Kinoshita S; Inatomi T; Ohashi Y; Uno T; Shimazaki J; Satake Y; Maeda N; Hori Y; Nishida K; Kubota A; Nakazawa T; Shimomura Y
Adv Ther; 2012 Apr; 29(4):339-49. PubMed ID: 22529026
[TBL] [Abstract][Full Text] [Related]
9. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing.
Levine JM; Noecker RJ; Lane LC; Herrygers L; Nix D; Snyder RW
J Cataract Refract Surg; 2004 Oct; 30(10):2177-82. PubMed ID: 15474833
[TBL] [Abstract][Full Text] [Related]
10. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients.
Kim DH; Stark WJ; O'Brien TP; Dick JD
Ophthalmology; 2005 Nov; 112(11):1992-6. PubMed ID: 16183125
[TBL] [Abstract][Full Text] [Related]
11. Concentration of moxifloxacin in serum and human aqueous humor following a single 400 mg oral dose.
Walter S; Kuchenbecker J; Banditt P; Bode-Böger SM; Behrens-Baumann W
J Cataract Refract Surg; 2007 Mar; 33(3):553-5. PubMed ID: 17321414
[No Abstract] [Full Text] [Related]
12. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.
Hariprasad SM; Mieler WE; Shah GK; Blinder KJ; Apte RS; Holekamp NM; Thomas MA; Chi J; Prince RA
Trans Am Ophthalmol Soc; 2004; 102():149-55; discussion 155-7. PubMed ID: 15747753
[TBL] [Abstract][Full Text] [Related]
13. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application.
Donnenfeld ED; Comstock TL; Proksch JW
J Cataract Refract Surg; 2011 Jun; 37(6):1082-9. PubMed ID: 21596251
[TBL] [Abstract][Full Text] [Related]
14. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
McCulley JP; Caudle D; Aronowicz JD; Shine WE
Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens.
Stewart WC; Crean CS; Zink RC; Brubaker K; Haque RM; Hwang DG
Am J Ophthalmol; 2010 Nov; 150(5):744-751.e2. PubMed ID: 20813346
[TBL] [Abstract][Full Text] [Related]
16. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery.
Ong-Tone L
J Cataract Refract Surg; 2008 May; 34(5):819-22. PubMed ID: 18471639
[TBL] [Abstract][Full Text] [Related]
17. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.
Hariprasad SM; Shah GK; Chi J; Prince RA
J Cataract Refract Surg; 2005 Nov; 31(11):2142-6. PubMed ID: 16412929
[TBL] [Abstract][Full Text] [Related]
18. Collagen shields as a drug delivery system for the fourth-generation fluoroquinolones.
Kleinmann G; Larson S; Hunter B; Stevens S; Mamalis N; Olson RJ
Ophthalmologica; 2007; 221(1):51-6. PubMed ID: 17183202
[TBL] [Abstract][Full Text] [Related]
19. Aqueous humor and plasma concentrations of ciprofloxacin and moxifloxacin following topical ocular administration in ophthalmologically normal horses.
Clode AB; Davis JL; Salmon J; LaFevers H; Gilger BC
Am J Vet Res; 2010 May; 71(5):564-9. PubMed ID: 20433383
[TBL] [Abstract][Full Text] [Related]
20. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery.
Ong-Tone L
J Cataract Refract Surg; 2007 Jan; 33(1):59-62. PubMed ID: 17189794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]